39 related articles for article (PubMed ID: 33761162)
1. Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.
Isakson P; Pardi C
Blood Transfus; 2023 Nov; 21(6):472-478. PubMed ID: 36795345
[TBL] [Abstract][Full Text] [Related]
2. Fetal
Schimanski B; Kräuchi R; Stettler J; Lejon Crottet S; Niederhauser C; Clausen FB; Fontana S; Hodel M; Amylidi-Mohr S; Raio L; Abbal C; Henny C
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893020
[TBL] [Abstract][Full Text] [Related]
3. Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy
Alford B; Landry BP; Hou S; Bower X; Bueno AM; Chen D; Husic B; Cantonwine DE; McElrath TF; Carozza JA; Wynn J; Hoskovec J; Gray KJ
Sci Rep; 2023 Aug; 13(1):12786. PubMed ID: 37550335
[TBL] [Abstract][Full Text] [Related]
4. A novel pyrosequencing strategy for RHD zygosity for predicting risk of hemolytic disease of the fetus and newborn.
Lv P; Li J; Yao Y; Fan X; Liu C; Li H; Zhou H
Lab Med; 2024 Mar; 55(2):145-152. PubMed ID: 37307496
[TBL] [Abstract][Full Text] [Related]
5. Detection of cell-free foetal DNA fraction in female-foetus bearing pregnancies using X-chromosomal insertion/deletion polymorphisms examined by digital droplet PCR.
Zednikova I; Pazourkova E; Lassakova S; Vesela B; Korabecna M
Sci Rep; 2020 Nov; 10(1):20036. PubMed ID: 33208834
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis.
Pedini P; Graiet H; Laget L; Filosa L; Chatron J; Cherouat N; Chiaroni J; Hubert L; Frassati C; Picard C
J Transl Med; 2021 Jan; 19(1):15. PubMed ID: 33407582
[TBL] [Abstract][Full Text] [Related]
7. The Most Favourable Procedure for the Isolation of Cell-Free DNA from the Plasma of Iso-Immunized RHD-Negative Pregnant Women.
Rather RA; Saha SC; Dhawan V
J Circ Biomark; 2015; 4():12. PubMed ID: 28936248
[TBL] [Abstract][Full Text] [Related]
8. Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.
Bedei I; Wolter A; Weber A; Signore F; Axt-Fliedner R
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805390
[TBL] [Abstract][Full Text] [Related]
9. Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.
Clausen FB; Hellberg Å; Bein G; Bugert P; Schwartz D; Drnovsek TD; Finning K; Guz K; Haimila K; Henny C; O'Brien H; Orzinska A; Sørensen K; Thorlacius S; Wikman A; Denomme GA; Flegel WA; Gassner C; de Haas M; Hyland C; Ji Y; Lane WJ; Nogués N; Olsson ML; Peyrard T; van der Schoot CE; Weinstock C; Legler T
Vox Sang; 2022 Feb; 117(2):157-165. PubMed ID: 34155647
[TBL] [Abstract][Full Text] [Related]
10. Determination of Advantages and Limitations of qPCR Duplexing in a Single Fluorescent Channel.
Zhang H; Yan Z; Wang X; Gaňová M; Chang H; Laššáková S; Korabecna M; Neuzil P
ACS Omega; 2021 Aug; 6(34):22292-22300. PubMed ID: 34497918
[TBL] [Abstract][Full Text] [Related]
11. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
12. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
[TBL] [Abstract][Full Text] [Related]
14. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
15. Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma.
Pazourkova E; Zednikova I; Korabecna M; Kralova J; Pisacka M; Novotna M; Calda P; Horinek A
Vox Sang; 2021 Oct; 116(9):1012-1019. PubMed ID: 33761162
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
